Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about IPSEY Recent news which mentions IPSEY FDA Fast-Tracks Ipsen And Genfit's New Liver Disease Treatment, Iqirvo June 11, 2024 Tickers GNFT IPSEF IPSEY NEWS Tags Equities News AI Generated From Benzinga 3 Promising Biotech Stocks Flying Under the Radar November 08, 2023 Tickers ABOS BMRN EXEL HALO Tags NASDAQ:BMRN,NASDAQ:EXEL,NASDAQ:HALO,OTCMKTS:IPSEY,NYSE:TAK,NASDAQ:ABOS Market News TAK From InvestorPlace Third Time Lucky: Exelixis' Cabozantinib Combo Therapy Aces Pivotal Study In Prostate Cancer Patients August 21, 2023 Tickers EXEL IPSEF IPSEY RHHBF Tags RHHVF IPSEF General From Benzinga Genfit's Miss Is CymaBay Therapeutics' Gain: Analyst Says Rival Data Leaves Room for Seladelpar To Emerge As Best-In-Class June 30, 2023 Tickers CBAY GNFT IPSEY Tags Analyst Ratings IPSEY Analyst Color From Benzinga Ipsen, Genfit's Elafibranor Shows Promise In Primary Biliary Cholangitis Patients June 30, 2023 Tickers GNFT IPSEY Tags Movers Biotech Benzinga From Benzinga What Now After FDA AdComm Rebuke for Intercept Pharmaceutical? Analyst Says Approval Of Intercept's 'OCA In NASH May Never Occur May 22, 2023 Tickers CBAY DRRX GNFT ICPT Tags DRRX CBAY FDA From Benzinga Why These Two Biotech Stocks Blasted Higher This Week January 13, 2023 Tickers ALBO AZN CINC IPSEY Tags IPSEY AZN CINC From Motley Fool 2 Tiny Nasdaq Stocks Making Major Merger Moves Monday January 09, 2023 Tickers ALBO DCT IPSEY Tags Market News DCT ^IXIC From Motley Fool France-Based Ipsen Acquires Albireo Pharma Enriching Its Rare Disease Portfolio, Pipeline January 09, 2023 Tickers ALBO IPSEF IPSEY Tags Eurasia General Small Cap From Benzinga Exelixis' Cabometyx/Tecentriq Combo Misses Overall Survival Goal In Lung Cancer Setting December 09, 2022 Tickers EXEL IPSEY RHHBY TAK Tags General IPSEY RHHBY From Benzinga Why Merrimack Shares Are Surging Over 200% Today? November 09, 2022 Tickers IPSEF IPSEY MACK Tags News Penny Stocks Trading Ideas From Benzinga Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know November 01, 2022 Tickers APLS ARDX AZN FOLD Tags FOLD AZN MGNX From Benzinga AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know October 02, 2022 Tickers ALNY AMLX AZN BLUE Tags Trading Ideas SUPN GSK From Benzinga Genfit To Buy This Swiss Firm Expanding Its Portfolio in Liver Diseases September 19, 2022 Tickers GNFT IPSEY Tags Market News M&A IPSEY From Benzinga Merrimack Pharma-Ipsen's Cancer Drug Fails In Overall Survival Measure August 03, 2022 Tickers IPSEF IPSEY MACK Tags why it's moving IPSEY Market News From Benzinga This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday June 28, 2022 Tickers AFIB AGRX AGTC AMST Tags NTRB BNTC APCX From Benzinga Why Adaptimmune Therapeutics Stock Is Popping Today June 27, 2022 Tickers ADAP EPZM IPSEY Tags IPSEY EPZM Market News From Motley Fool Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session June 27, 2022 Tickers AFIB AGRX AGTC ARMP Tags Penny Stocks AVTX Mid/Day Movers From Benzinga Why Epizyme Stock Is Soaring Today June 27, 2022 Tickers EPZM IPSEY Tags EPZM Market News Recent Press Releases From Motley Fool The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies June 27, 2022 Tickers ALPMF ALPMY AXSM AZN Tags AZNCF DSNKY General From Benzinga Ipsen Scoops Up Blood Cancer-Focused Epizyme - Read Why June 27, 2022 Tickers EPZM IPSEF IPSEY Tags Health Care EPZM Trading Ideas From Benzinga Buying These 3 Stocks Could Be the Smartest Investing Move You Ever Make May 17, 2022 Tickers BMY ETSY EXEL IPSEY Tags Recent Press Releases ISRG TKPHF From Motley Fool The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs May 03, 2022 Tickers ACAD AQST BIIB BLTE Tags PFE OCUL Benzinga From Benzinga Ipsen - Exelixis' Cabometyx Scores European Approval As Second-Line Treatment For Thyroid Cancer May 03, 2022 Tickers EXEL IPSEF IPSEY Tags Health Care Benzinga Biotech From Benzinga EMA's Scientific Committee Backs Expanded Use Of Exelixis, Ipsen's Cabometyx In Thyroid Cancer March 25, 2022 Tickers EXEL IPSEF IPSEY Tags News Briefs EXEL From Benzinga Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy March 15, 2022 Tickers BAYRY BAYZF EXEL IPSEY Tags RHHBY IPSEY Market News From Benzinga A Peek Into The Markets: US Stock Futures Down Following Friday's Plunge January 24, 2022 Tickers ABBV GILD HAL IBM Tags Markets GILD Market News From Benzinga Ipsen's Sohonos Scores Canadian Approval For Rare Connective Tissue Disease January 24, 2022 Tickers IPSEF IPSEY Tags IPSEY General IPSEF From Benzinga GNFT Stock Alert: 15 Things to Know About Biotech Penny Stock Genfit as Shares Go Gangbusters December 17, 2021 Tickers BABA FUTU GNFT IPSEY Tags FUTU NASDAQ:GNFT,OTCMKTS:IPSEY,NYSE:BABA,NASDAQ:NVAX,NASDAQ:FUTU Uncategorized From InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday December 17, 2021 Tickers ABEO ADGI BLIN CERN Tags TIGR ADGI FUTU From InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.